Cargando…

Associations between epidermal growth factor receptor mutations and histological subtypes of lung adenocarcinoma according to the IASLC/ATS/ERS classification in Chinese patients

BACKGROUND: This retrospective study was conducted to investigate the relationship between epidermal growth factor receptor (EGFR) mutation and histological subtypes of lung adenocarcinoma according to the International Association for the Study of Lung Cancer/American Thoracic Society/European Resp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Tengteng, Zhang, Yi, Liu, Baodong, Hu, Mu, Zhou, Naikang, Zhi, Xiuyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668489/ https://www.ncbi.nlm.nih.gov/pubmed/28940943 http://dx.doi.org/10.1111/1759-7714.12489

Ejemplares similares

Correlation of Epidermal Growth Factor Receptor Mutation With Major Histologic Subtype of Lung Adenocarcinoma According to IASLC/ATS/ERS Classification
por: Boukansa, Sara, et al.
Publicado: (2022)

Cancer stem cell-related marker expression in lung adenocarcinoma and relevance of histologic subtypes based on IASLC/ATS/ERS classification
por: Shimada, Yoshihisa, et al.
Publicado: (2013)

Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinoma
por: Zabeck, Heike, et al.
Publicado: (2018)

Association of Lung Adenocarcinoma Subtypes According to the IASLC/ATS/ERS Classification and Programmed Cell Death Ligand 1 (PD-L1) Expression in Tumor Cells
por: Cruz-Rico, Graciela, et al.
Publicado: (2021)

Correlation between EML4-ALK, EGFR and clinicopathological features based on IASLC/ATS/ERS classification of lung adenocarcinoma
por: Wang, Hongyan, et al.
Publicado: (2018)

Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma
por: Sun, Yifeng, et al.
Publicado: (2016)

Clinicopathological and prognostic significance of metastasis-associated protein 1 expression and its correlation with angiogenesis in lung invasive adenocarcinomas, based on the 2011 IASLC/ATS/ERS classification
por: LI, SHUHAI, et al.
Publicado: (2016)

Expression and prognostic value of GalNAc-T3 in patients with completely resected small (≤2 cm) peripheral lung adenocarcinoma after IASLC/ATS/ERS classification
por: Zhao, Shilei, et al.
Publicado: (2015)

肺腺癌IASLC/ATS/ERS国际多学科分类以及临床实践中应注意的问题
Publicado: (2013)

Comment on “EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach”
por: Vigneswaran, Wickii T., et al.
Publicado: (2020)

Prognosis of resected invasive mucinous adenocarcinoma compared with the IASLC histologic grading system for invasive nonmucinous adenocarcinoma: Surgical database study in the TKIs era in Korea
por: Woo, Wongi, et al.
Publicado: (2022)

From the IASLC Tobacco Control Committee
Publicado: (2020)

From the IASLC Tobacco Control Committee
Publicado: (2020)

From the IASLC Tobacco Control Committee
Publicado: (2020)

From the IASLC Tobacco Control Committee
Publicado: (2020)

Correlation of survival and EGFR mutation with predominant histologic subtype according to the new lung adenocarcinoma classification in stage IB patients
por: Sun, Yan, et al.
Publicado: (2014)

A Simplified Version of the IASLC Grading System for Invasive Pulmonary Adenocarcinomas With Improved Prognosis Discrimination
por: Bossé, Yohan, et al.
Publicado: (2023)

Volume and Mass Doubling Time of Lung Adenocarcinoma according to WHO Histologic Classification
por: Hong, Jung Hee, et al.
Publicado: (2021)

IASLC Textbook of Prevention and Early Detection of Lung Cancer
por: Spiro, S G
Publicado: (2006)

The IASLC grading system for invasive pulmonary adenocarcinoma: a potential prognosticator for patients receiving neoadjuvant therapy
por: E, Haoran, et al.
Publicado: (2023)

A pretreatment prediction model of grade 3 tumors classed by the IASLC grading system in lung adenocarcinoma
por: Wang, Kai, et al.
Publicado: (2023)

Relationship of epidermal growth factor receptor activating mutations with histologic subtyping according to International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society 2011 adenocarcinoma classification and their impact on overall survival
por: Maturu, Venkata Nagarjuna, et al.
Publicado: (2016)

Experience with the ATS optics
por: Fartoukh, S
Publicado: (2017)

ATS MD’s in 2016
por: Fartoukh, Stephane, et al.
Publicado: (2016)

NRITLD-ATS 2012
por: Masjedi, Mohammad Reza, et al.
Publicado: (2012)

Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
por: Nahid, Payam, et al.
Publicado: (2019)

ATS and our Journal Collaboration
por: Mortaz, Esmaeil
Publicado: (2012)

Controversies and challenges in the histologic subtyping of lung adenocarcinoma
por: Butnor, Kelly J.
Publicado: (2020)

The revised ATS/ERS/JRS/ALAT diagnostic criteria for idiopathic pulmonary fibrosis (IPF) - practical implications
por: Wells, Athol U
Publicado: (2013)

Erratum: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
Publicado: (2020)

New International Association for the Study of Lung Cancer (IASLC) Pathology Committee Grading System for the Prognostic Outcome of Advanced Lung Adenocarcinoma
por: Weng, Ching-Fu, et al.
Publicado: (2020)

A predictive nomogram for lymph node metastasis in part-solid invasive lung adenocarcinoma: A complement to the IASLC novel grading system
por: Gao, Zhaoming, et al.
Publicado: (2022)

Short Summaries of the ATS Seminars in 2022
por: Metral, Elias, et al.
Publicado: (2023)

The 10 cm beta* ATS MD
por: Fartoukh, S, et al.
Publicado: (2013)

Adenocarcinoma with mixed subtypes is a rare but aggressive histologic subtype in colorectal cancer
por: Sheng, Hui, et al.
Publicado: (2019)

Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma
por: Schueneman, A, et al.
Publicado: (2015)

Supplementary Prognostic Variables for Pleural Mesothelioma: A Report from the IASLC Staging Committee
por: Pass, Harvey I., et al.
Publicado: (2014)

A Proposal to Modify the 8th IASLC System: Is it Suitable for T4N2M0 Lung Adenocarcinoma to Be Placed in Stage IIIB?
por: Ruan, Tian, et al.
Publicado: (2022)

Classification of epidermal keratins according to their immunoreactivity, isoelectric point, and mode of expression
Publicado: (1984)

ATS/CDC/ERS/IDSA Clinical Practice Guidelines for Treatment of Drug-Resistant Tuberculosis: A Two-edged Sword?
por: Chang, Kwok-Chiu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_965njm2ttu8q3jle4c667end6l